Release Date: 31/07/09 09:30 Summary: Quarterly Activities Report and Appendix 5B Price Sensitive: Yes Download Document 667.52KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%